PedAM
Pediatric Disease Annotations & Medicines
| Disease | cystic fibrosis |
| Phenotype | C0004031|allergic bronchopulmonary aspergillosis |
| Sentences | 20 |
| PubMedID- 20127304 | Typical acute complications are infective exacerbations - the most frequent cause of death in cystic fibrosis - along with allergic bronchopulmonary aspergillosis, haemoptyses and pneumothoraces. |
| PubMedID- 20714107 | Vitamin d3 attenuates th2 responses to aspergillus fumigatus mounted by cd4+ t cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. |
| PubMedID- 26003072 | The classic diagnostic criteria of allergic bronchopulmonary aspergillosis in cystic fibrosis have been established during the cystic fibrosis foundation conference in 2001. |
| PubMedID- 21246055 | The ubiquitous fungus aspergillus fumigatus is associated with chronic diseases such as invasive pulmonary aspergillosis in immunosuppressed patients and allergic bronchopulmonary aspergillosis (abpa) in patients with cystic fibrosis or severe asthma. |
| PubMedID- 22731696 | It is conceivable that high il-10 levels could contribute to the resolution of the aspergillus induced pulmonary inflammation, but high il-10 concentrations have also been associated with development of invasive aspergillosis in non-neutropenic immunocompromised patients and with colonization with a. fumigatus and allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [26]. |
| PubMedID- 24043500 | Objectives: to evaluate the efficacy and adverse effects of anti-ige therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. |
| PubMedID- 25150265 | Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. |
| PubMedID- 25705310 | allergic bronchopulmonary aspergillosis in patient with cystic fibrosis - a case report. |
| PubMedID- 23278646 | Hla-drb1 and hla-dqb1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. |
| PubMedID- 21067334 | Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges. |
| PubMedID- 26187954 | allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
| PubMedID- 25354514 | allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated. |
| PubMedID- 25010610 | Anti ige antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. |
| PubMedID- 22608296 | Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens. |
| PubMedID- 22696329 | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. |
| PubMedID- 24167019 | Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence. |
| PubMedID- 20597074 | Risk factors for aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. |
| PubMedID- 25431975 | Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. |
| PubMedID- 25015245 | [role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis]. |
| PubMedID- 23278535 | Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. |
Page: 1